Cancer International Research Group Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Edmonton Canada (2001)

Organization Overview

First Clinical Trial
2001
NCT00688740
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Cancer International Research Group (CIRG)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 9